Professional
Added to YB: 2024-10-10
Pitch date: 2024-10-07
MEDP [bullish]
Medpace Holdings, Inc.
+49.18%
current return
Author Info
No bio for this author
Company Info
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
Market Cap
$12.8B
Pitch Price
$332.49
Price Target
N/A
Dividend
N/A
EV/EBITDA
20.52
P/E
29.53
EV/Sales
4.92
Sector
Life Sciences Tools and Services
Category
turnaround
Headwaters Capital Portfolio Holding: Medpace Holdings, Inc.
MEDP: -19% on slowing bookings & trial cancellations. Cyclical biotech funding impacts, but long-term growth intact. 5% market share in CRO for biotechs. Strong capital allocation: 16% shares repurchased in 2022 downturn. $700M cash + $500M FCF in 2024 enables 10%+ buyback if weakness persists.
Read full article (1 min)